Friday, Jan 17, 2025 · SEC filings

What the smart money revealed on Jan 17

Real insider buys24insiders · $2.59M
Real insider sales54insiders · $11.6M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

647 insider filings came in. We hid 85 planned (10b5-1) sellers and 462 people whose filings were routine, like grants and tax withholding.

trending_up

Blue Owl Technology Finance Corp. II President Erik Bissonnette bought $896K

57,311 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 15
$896K
trending_up

ASA Gold & Precious Metals (ASA) COO Alexander Merk bought $687K

31,248 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 4 beat Traded Jan 16
$687K
trending_up

CME Group (CME) Director William Shepard bought $326K

1,429 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 10 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 10 beat Traded Jan 16
$326K
trending_up

RxSight (RXST) Director Jesse Corley bought $100K

3,210 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 15–16
$100K
trending_down

AAR (AIR) Senior Vice President-CCO Christopher Jessup sold $2.39M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 63,209 shares directly.

Real sale Form 4 Traded Jan 15–16
$2.39M
trending_down

Ionis Pharmaceuticals (IONS) CEO Brett Monia sold $1.09M

Not marked as a planned 10b5-1 sale. Sold 14% of the shares they held directly. Still holds 207,396 shares.

Real sale Form 4 Traded Jan 16
$1.09M
trending_down

Darden Restaurants (DRI) Director M. Shan Atkins sold $199K

Not marked as a planned 10b5-1 sale. Sold 52% of the shares they held directly. Still holds 1,014 shares.

Real sale Form 4 Sold 52% of stake Traded Jan 15
$199K
Show 20 more real buys
THFF First Financial · Director Michael Carty · Traded Nov 22–May 1
$93.7K
AVIR Atea Pharmaceuticals · Director Franklin Berger · Traded Jan 15–16
$81.5K
MKZR MacKenzie Realty Capital · CEO/President Robert Dixon · Traded Jan 16–17
$66.8K
KYN Kayne Anderson Energy Infrastructure Fund · Executive Vice President Harrison Little · Traded Jan 17
$65.2K
FIS Fidelity National Information Services · Director Jeffrey Goldstein · Traded Jan 15
$56.1K
COSM Cosmos Health · CEO Grigorios Siokas · Traded Jan 16
$40.2K
Blue Owl Technology Finance Corp. II · Director Victor Woolridge · Traded Jan 15
$36.8K
FRD Friedman Industries · President / CEO / Director Mike Taylor · Traded Jan 15
$35.2K
CHMG Chemung Financial · Director Joseph Meade IV · Traded Jan 15
$28K
ANIX Anixa Biosciences · Director Lewis Titterton Jr. · Traded Jan 17
$25.7K
BRN Barnwell Industries · CEO Craig Hopkins · Traded Jan 17
$16.5K
AWF AllianceBernstein Global High Income Fund · Vice President Gershon Distenfeld · Traded Jan 15
$15.2K
BDCO Blue Dolphin Energy · CEO and President Jonathan Carroll · Traded Jan 15
$3.5K
BDCO Blue Dolphin Energy · PFO Bryce Klug · Traded Jan 15
$3.4K
RCG RENN Fund · President and CEO Murray Stahl · Traded Jan 16
$3.19K
KWY Kingsway Financial Services · President and CEO John Fitzgerald · Traded Jan 16
$2.5K
BSIN US Energy · CEO Ryan Smith · Traded Jan 15–16
$2.19K
DAKT Daktronics · Secretary and VP of Human Reso Carla Gatzke · Traded Jun 24
$1.88K
KWY Kingsway Financial Services · CFO and EVP Kent Hansen · Traded Jan 16
$315
ISBA Isabella Bank · Director Jill Bourland · Traded Jan 16
$200
Show 51 more real sales
KMX CarMax · VP Jill Livesay · Traded Jan 15
$1.05M
PNRG Primeenergy Resources · Director Clint Hurt · Traded Jan 15–16
$823K
SSII SS Innovations International · Chairman and CEO Sudhir Srivastava · Traded Jan 17
$499K
MDGL Madrigal Pharmaceuticals · Pres. Rebecca Taub · Traded Jan 17
$462K
KMX CarMax · EVP and CFO Enrique Mayor-Mora · Traded Jan 15
$407K
ILLR Triller Group · Director Robert Diamond Jr. · Traded Jan 15–17
$318K
IONS Ionis Pharmaceuticals · EVP Elizabeth Hougen · Traded Jan 16
$291K
IONS Ionis Pharmaceuticals · EVP CLO and General Counsel Patrick O'neil · Traded Jan 16
$242K
IONS Ionis Pharmaceuticals · EVP Research Eric Swayze · Traded Jan 16
$236K
IONS Ionis Pharmaceuticals · EVP Richard Geary · Traded Jan 16
$232K
IONS Ionis Pharmaceuticals · EVP C. Frank Bennett · Traded Jan 16
$222K
IONS Ionis Pharmaceuticals · EVP Eugene Schneider · Traded Jan 16
$214K
IMVT Immunovant · CEO Peter Salzmann · Traded Jan 15
$209K
GDDY GoDaddy · CFO Mark McCaffrey · Traded Jul 2–Jan 6
$185K
WWW Wolverine World Wide · President Isabel Soriano · Traded Nov 25
$181K
IONS Ionis Pharmaceuticals · EVP Brian Birchler · Traded Jan 16
$177K
WMT Walmart · Executive Vice President Daniel Bartlett · Traded Jan 15
$167K
CADL Candel Therapeutics · CEO Paul Tak · Traded Jan 15
$157K
AMBA Ambarella · COO Chan Lee · Traded Jan 15–16
$153K
IONS Ionis Pharmaceuticals · EVP Joseph Baroldi · Traded Jan 16
$145K
IONS Ionis Pharmaceuticals · EVP Shannon Devers · Traded Jan 16
$140K
MDGL Madrigal Pharmaceuticals · Senior VP Robert Waltermire · Traded Jan 17
$121K
CADL Candel Therapeutics · CTO Seshu Tyagarajan · Traded Jan 15
$104K
CADL Candel Therapeutics · Chief Scientific Officer Francesca Barone · Traded Jan 15
$97.9K
QMCO Quantum · President and CEO James Lerner · Traded Jan 16
$89.6K
ETN Eaton · Director Dorothy Thompson · Traded Aug 13
$82.5K
PHR Phreesia · CEO Chaim Indig · Traded Jan 15
$80.7K
MDGL Madrigal Pharmaceuticals · General Counsel Shannon Kelley · Traded Jan 17
$75.7K
CADL Candel Therapeutics · Chief Medical Officer William Nichols · Traded Jan 15
$75.4K
QMCO Quantum · SVP Chief Admin Ofcr and Secy Brian Cabrera · Traded Nov 8–Jan 16
$72.5K
CADL Candel Therapeutics · Officer Charles Schoch · Traded Jan 15
$68.8K
IMVT Immunovant · Chief Medical Officer William Macias · Traded Jan 15
$56.8K
IMVT Immunovant · CFO Eva Barnett · Traded Jan 15
$54.8K
QMCO Quantum · CFO Kenneth Gianella · Traded Jan 16
$53.1K
PHR Phreesia · SVP David Linetsky · Traded Jan 15
$52.5K
ANGO Angiodynamics · SVP Quality and Regulatory Warren Nighan Jr. · Traded Jan 16
$50K
PHR Phreesia · COO Evan Roberts · Traded Jan 15
$48.2K
BE Bloom Energy · Officer Shawn Soderberg · Traded Jan 16
$38.4K
NKTX Nkarta · CEO Paul Hastings · Traded Jan 15
$38.2K
QMCO Quantum · Chief Revenue Officer Henk Spanjaard · Traded Jan 16
$33.4K
PHR Phreesia · CFO Balaji Gandhi · Traded Jan 15
$22.6K
NKTX Nkarta · Chief Legal Officer Alicia Hager · Traded Jan 15
$21.1K
NKTX Nkarta · Officer David Shook · Traded Jan 15
$19K
ADAPY Adaptimmune Therapeutics · CEO Adrian Rawcliffe · Traded Jan 17
$17.7K
NKTX Nkarta · Chief Technical Officer Ralph Brandenberger · Traded Jan 15
$16.4K
PHR Phreesia · SVP Amy VanDuyn · Traded Jan 15
$16.3K
NKTX Nkarta · Officer Alyssa Levin · Traded Jan 15
$12.8K
DAKT Daktronics · Exec Vice President Bradley Wiemann · Traded Jul 16
$9.06K
CBUS Cibus · Director Gerhard Prante · Traded Jan 15–16
$6.11K
ADAPY Adaptimmune Therapeutics · COO William Bertrand Jr. · Traded Jan 17
$3.24K
IGMS IGM Biosciences · Principal Accounting Officer Steven Weber · Traded Jan 15
$1.91K

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 11–17

Open-market buys by officers and directors, filed in the 7 days up to Jan 17.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist